Sculptor Capital’s AstraZeneca AZN Stock Holding History

Sculptor Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-33,686	Closed	-$4.45M	–	1087
2022 Q2	$4.45M	Sell	33,686 -386,480	-92%	-$50.7M	0.05%	440
2022 Q1	$55.7M	Buy	420,166 +257,754	+159%	+$30.9M	0.43%	41
2021 Q4	$18.9M	Buy	+162,412	New	+$19.1M	0.16%	96
2019 Q2	–	Sell	-123,443	Closed	-$9.98M	–	275
2019 Q1	$9.98M	Buy	+123,443	New	+$9.73M	0.06%	81
2014 Q3	–	Sell	-14,600	Closed	-$1.08M	–	763
2014 Q2	$1.08M	Buy	+14,600	New	+$1.06M	﹤0.01%	657

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Sculptor Capital's AZN Position: Q3 2022 in Review

Sculptor Capital sold out of AstraZeneca (AZN) in Q3 2022, closing a stake of 33,686 shares — an estimated $4.45M sold.

Sculptor Capital first reported a position in AZN in Q2 2014 and held it in 5 quarters. The position peaked at $55.7M in Q1 2022. 965 funds tracked by Wall St. Rank hold AZN as of Q3 2022.

Sculptor Capital reported no remaining AstraZeneca position as of Q3 2022 after selling out during the quarter.
Sculptor Capital sold 33,686 AstraZeneca shares in Q3 2022, an estimated $4.45M.
Sculptor Capital first reported a position in AstraZeneca in Q2 2014 and held it in 5 quarters.
Sculptor Capital's AstraZeneca position peaked at $55.7M in Q1 2022.
965 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2022.

Based on Sculptor Capital's 13F filing for Q3 2022, filed 14 Nov 2022.